Ajanta Pharma Ltd has received an approval from the US Food and Drug Administration (USFDA) for Fluphenazine Hydrochloride tablet, as per an exchange filing.
The dosage is in 1 mg, 2.5 mg, 5 mg and 10 mg strengths, according to an update on the drug regulator's website.
The drug is used to treat psychotic disorders such as schizophrenia.
Uttar Pradesh News: Centre Clears 11.56 Km Noida Metro Extension From Sector 142 To Botanical Garden
Uttar Pradesh News: Yogi Government Launches ‘Tech Yuva-Samarth Yuva’ To Train 2.5 Million Youth In AI And Immersive Technologies
Uttar Pradesh News: CM Yogi Adityanath Inaugurates Gorakhpur’s Fifth Kalyan Mandapam, Calls City A Model Of Development
Uttar Pradesh Budget 2026–27 Boosts Religious Tourism With Major Funding For Pilgrimage Site Development
